Professional Documents
Culture Documents
Government of India
Ministry of Chemicals and Fertilizers
Department of Pharmaceuticals
National Pharmaceutical Pricing Authority
ORDER
S.O. 937(E):-In exercise of the powers conferred by paragraphs 5, 11 and 15 of the Drugs (Prices
Control) Order, 2013, read with S.O. 1394(E) dated the 30th May, 2013 and S. O. 5249(E) dated
11th November, 2022 issued by the Government of India in the Ministry of Chemicals and
Fertilizers, the National Pharmaceutical Pricing Authority (hereinafter referred as NPPA),
hereby fixes, the price as specified in column (6) of the table herein below as the retail price,
exclusive of Goods and Services Tax, if any, in relation to the formulation specified in the
corresponding entry in column (2) of the said Table with the strength, unit and name of
manufacturer & marketing company, as specified in the corresponding entries in columns (3),
(4) and (5) thereof;
Table
Part-I
Ceftriaxone and Tazobactam
for Injection 1125mg
Each vial contains:
Ceftriaxone Sodium IP
(Sterile) eq. to Ceftriaxone M/s East African
Ceftriaxone and 1gm, (India) Overseas /
37 Tazobactam Tazobactam Sodium IP 1 Vial M/s Softdeal 189.45
injection (Sterile) eq. to Tazobactam Pharmaceuticals
125mg Private Limited
Part-II
(For Reconstitution)
Each FFS
Ampoule contains:
Sterile Water for Injection IP
10ml
M/s Windlas
Each film coated bilayered
Telmisartan & Biotech Ltd. (Plant
tablet contains:
38 Cilnidipine 1 Tablet 2) / M/s Emcure 10.39
Telmisartan IP 40mg
Tablet Pharmaceuticals
Cilnidipine IP 10mg
Limited
M/s Pure and Cure
Diclofenac Each uncoated tablet
Healthcare Pvt.
Sodium & contains:
39 1 Tablet Ltd. / M/s Softdeal 4.99
Paracetamol Diclofenac Sodium IP 50mg,
Pharmaceuticals
Tablets Paracetamol IP 325mg
Private Limited
Vitamin D3 Each ml contains:
M/s SAF Fermion
40 (Cholecalciferol) Vitamin D3 (Cholecalciferol) 1 ml 5.53
Limited
Oral Drops 800IU
M/s Akums Drugs
Each film coated tablet and
Telmisartan &
contains: Pharmaceuticals
41 Chlorthalidone 1 Tablet 5.35
Telmisartan IP 40mg Ltd. / M/s Blue
Tablet
Chlorthalidone 6.25mg Cross Laboratories
Pvt. Ltd.
M/s Akums Drugs
Each film coated tablet and
Telmisartan &
contains: Pharmaceuticals
42 Chlorthalidone 1 Tablet 6.25
Telmisartan IP 40mg Ltd. / M/s Blue
Tablet
Chlorthalidone 12.50mg Cross Laboratories
Pvt. Ltd.
Itraconazole M/s Synokem
Capsules 130mg Each hard gelatin capsule Pharmaceuticals
1
43 (Supra- contains: Ltd. / M/s Aristo 19.50
Capsule
Bioavailable Itraconazole BP 130mg Pharmaceuticals
Formulation) Pvt. Ltd.
Linagliptin, Each film coated bilayered M/s Mascot Health
44 Metformin tablet contains: 1 Tablet Series Pvt. Ltd. / 13.03
Hydrochloride Linagliptin 5mg M/s Torrent
Sl. Name of the Strength Unit Manufacturer & Retail
No. Formulation / Marketing Price
Brand Name Company (Rs.)
(1) (2) (3) (4) (5) (6)
(Extended Metformin Hydrochloride IP Pharmaceuticals
Release) Tablets 500mg (As Extended Ltd.
Release)
Each film coated bilayered
Linagliptin, M/s Synokem
tablet contains:
Metformin Pharmaceuticals
Linagliptin 5mg
45 Hydrochloride 1 Tablet Limited / M/s 14.65
Metformin Hydrochloride IP
(Extended Mankind Pharma
1000mg (As Extended
Release) Tablets Limited
Release)
Each film coated bilayered
Dapagliflozin, tablet contains:
Metformin Dapagliflozin Propanediol M/s Mascot Health
Hydrochloride USP eq. to Dapagliflozin Series Pvt. Ltd. /
46 (Extended 10mg 1 Tablet M/s Eris 14.65
Release) and Metformin Hydrochloride IP Lifesciences
Glimepiride 1000mg (As Extended Limited
Tablets release)
Glimepiride IP 1 mg
Each film coated bilayered
Dapagliflozin, tablet contains:
Metformin Dapagliflozin Propanediol
M/s Mascot Health
Hydrochloride USP eq. to Dapagliflozin
Series Pvt. Ltd. /
47 (Extended 10mg 1 Tablet 14.44
M/s Mankind
Release) and Metformin Hydrochloride IP
Pharma Ltd.
Glimepiride 1000mg (As Extended
Tablets release)
Glimepiride IP 1 mg
Each film coated bilayered
Dapagliflozin, tablet contains:
Metformin Dapagliflozin Propanediol M/s Mascot Health
Hydrochloride USP eq. to Dapagliflozin Series Pvt. Ltd. /
48 (Extended 10mg 1 Tablet M/s Alkem 14.65
Release) and Metformin Hydrochloride IP Laboratories
Glimepiride 1000mg (As Extended Limited
Tablets release)
Glimepiride IP 1 mg
Each film coated bilayered
Dapagliflozin, tablet contains:
Metformin Dapagliflozin Propanediol M/s Mascot Health
Hydrochloride USP eq. to Dapagliflozin Series Pvt. Ltd. /
49 (Extended 10mg 1 Tablet M/s Torrent 14.65
Release) and Metformin Hydrochloride IP Pharmaceuticals
Glimepiride 1000mg (As Extended Limited
Tablets release)
Glimepiride IP 1 mg
Each film coated bilayered
Dapagliflozin,
tablet contains:
Metformin
Dapagliflozin Propanediol
Hydrochloride M/s Mascot Health
USP eq. to Dapagliflozin
50 (Extended 1 Tablet Series Pvt. Ltd. / 14.44
10mg
Release) and M/s Lupin Limited
Metformin Hydrochloride IP
Glimepiride
1000mg (As Extended
Tablets
release)
Sl. Name of the Strength Unit Manufacturer & Retail
No. Formulation / Marketing Price
Brand Name Company (Rs.)
(1) (2) (3) (4) (5) (6)
Glimepiride IP 1 mg
Each film coated bilayered
Dapagliflozin, tablet contains:
Metformin Dapagliflozin Propanediol M/s Mascot Health
Hydrochloride USP eq. to Dapagliflozin Series Pvt. Ltd. /
51 (Extended 10mg 1 Tablet M/s Medley 14.44
Release) and Metformin Hydrochloride IP Pharmaceuticals
Glimepiride 1000mg (As Extended Ltd.
Tablets release)
Glimepiride IP 1 mg
Each film coated bilayered
Dapagliflozin, tablet contains:
Metformin Dapagliflozin Propanediol M/s Mascot Health
Hydrochloride USP eq. to Dapagliflozin Series Pvt. Ltd. /
52 (Extended 10mg 1 Tablet M/s Eris 16.33
Release) and Metformin Hydrochloride IP Lifesciences
Glimepiride 1000mg (As Extended Limited
Tablets release)
Glimepiride IP 2 mg
Each film coated bilayered
Dapagliflozin, tablet contains:
Metformin Dapagliflozin Propanediol
M/s Mascot Health
Hydrochloride USP eq. to Dapagliflozin
Series Pvt. Ltd. /
53 (Extended 10mg 1 Tablet 16.12
M/s Mankind
Release) and Metformin Hydrochloride IP
Pharma Ltd.
Glimepiride 1000mg (As Extended
Tablets release)
Glimepiride IP 2 mg
Each film coated bilayered
Dapagliflozin, tablet contains:
Metformin Dapagliflozin Propanediol M/s Mascot Health
Hydrochloride USP eq. to Dapagliflozin Series Pvt. Ltd. /
54 (Extended 10mg 1 Tablet M/s Alkem 16.33
Release) and Metformin Hydrochloride IP Laboratories
Glimepiride 1000mg (As Extended Limited
Tablets release)
Glimepiride IP 2 mg
Each film coated bilayered
Dapagliflozin, tablet contains:
Metformin Dapagliflozin Propanediol M/s Mascot Health
Hydrochloride USP eq. to Dapagliflozin Series Pvt. Ltd. /
55 (Extended 10mg 1 Tablet M/s Torrent 16.33
Release) and Metformin Hydrochloride IP Pharmaceuticals
Glimepiride 1000mg (As Extended Limited
Tablets release)
Glimepiride IP 2 mg
Dapagliflozin, Each film coated bilayered
Metformin tablet contains:
Hydrochloride Dapagliflozin Propanediol M/s Mascot Health
56 (Extended USP eq. to Dapagliflozin 1 Tablet Series Pvt. Ltd. / 16.12
Release) and 10mg M/s Lupin Limited
Glimepiride Metformin Hydrochloride IP
Tablets 1000mg (As Extended
Sl. Name of the Strength Unit Manufacturer & Retail
No. Formulation / Marketing Price
Brand Name Company (Rs.)
(1) (2) (3) (4) (5) (6)
release)
Glimepiride IP 2 mg
Each film coated bilayered
Dapagliflozin, tablet contains:
Metformin Dapagliflozin Propanediol M/s Mascot Health
Hydrochloride USP eq. to Dapagliflozin Series Pvt. Ltd. /
57 (Extended 10mg 1 Tablet M/s Medley 16.12
Release) and Metformin Hydrochloride IP Pharmaceuticals
Glimepiride 1000mg (As Extended Ltd.
Tablets release)
Glimepiride IP 2 mg
Each film coated tablet
Sitagliptin contains:
Phosphate, Sitagliptin Phosphate
M/s Exemed
Metformin Monohydrate IP eq. to
58 1 Tablet Pharmaceuticals / 12.00
Hydrochloride Sitagliptin 50mg
M/s Cipla Ltd.
and Glimepiride Metformin Hydrochloride IP
Tablets 1000mg
Glimepiride IP 1 mg
Each film coated tablet
Sitagliptin contains:
M/s Synokem
Phosphate, Sitagliptin Phosphate
Pharmaceuticals
Metformin Monohydrate IP eq. to
59 1 Tablet Ltd. /M/s Alkem 13.35
Hydrochloride Sitagliptin 50mg
Laboratories
and Glimepiride Metformin Hydrochloride IP
Limited
Tablets 1000mg
Glimepiride IP 1 mg
Each film coated tablet
Sitagliptin contains:
M/s Synokem
Phosphate, Sitagliptin Phosphate
Pharmaceuticals
Metformin Monohydrate IP eq. to
60 1 Tablet Ltd. /M/s Intas 13.00
Hydrochloride Sitagliptin 50mg
Pharmaceuticals
and Glimepiride Metformin Hydrochloride IP
Ltd.
Tablets 1000mg
Glimepiride IP 1 mg
Each film coated tablet
Sitagliptin contains:
Phosphate, Sitagliptin Phosphate
M/s Exemed
Metformin Monohydrate IP eq. to
61 1 Tablet Pharmaceuticals / 14.00
Hydrochloride Sitagliptin 50mg
M/s Cipla Ltd.
and Glimepiride Metformin Hydrochloride IP
Tablets 1000mg
Glimepiride IP 2 mg
Each film coated tablet
Sitagliptin contains:
M/s Synokem
Phosphate, Sitagliptin Phosphate
Pharmaceuticals
Metformin Monohydrate IP eq. to
62 1 Tablet Ltd. /M/s Alkem 15.03
Hydrochloride Sitagliptin 50mg
Laboratories
and Glimepiride Metformin Hydrochloride IP
Limited
Tablets 1000mg
Glimepiride IP 2 mg
Sitagliptin Each film coated tablet M/s Synokem
63 1 Tablet 15.00
Phosphate, contains: Pharmaceuticals
Sl. Name of the Strength Unit Manufacturer & Retail
No. Formulation / Marketing Price
Brand Name Company (Rs.)
(1) (2) (3) (4) (5) (6)
Metformin Sitagliptin Phosphate Ltd. /M/s Intas
Hydrochloride Monohydrate IP eq. to Pharmaceuticals
and Glimepiride Sitagliptin 50mg Ltd.
Tablets Metformin Hydrochloride IP
1000mg
Glimepiride IP 2 mg
Each film coated bilayered
Dapagliflozin, tablet contains:
Metformin Dapagliflozin Propanediol M/s Mascot Health
Hydrochloride USP eq. to Dapagliflozin Series Pvt. Ltd. /
64 (Extended 10mg 1 Tablet M/s Torrent 13.24
Release) and Metformin Hydrochloride IP Pharmaceuticals
Glimepiride 500mg (As Extended Limited
Tablets release)
Glimepiride IP 1 mg
Each film coated bilayered
Dapagliflozin, tablet contains:
Metformin Dapagliflozin Propanediol M/s Mascot Health
Hydrochloride USP eq. to Dapagliflozin Series Pvt. Ltd. /
14.75
65 (Extended 10mg 1 Tablet M/s Torrent
Release) and Metformin Hydrochloride IP Pharmaceuticals
Glimepiride 500mg (As Extended Limited
Tablets release)
Glimepiride IP 2 mg
Each film coated bilayered
Dapagliflozin, tablet contains:
Metformin Dapagliflozin Propanediol M/s Mascot Health
Hydrochloride USP eq. to Dapagliflozin Series Pvt. Ltd. /
66 (Extended 10mg 1 Tablet M/s Alkem 14.92
Release) and Metformin Hydrochloride IP Laboratories
Glimepiride 500mg (As Extended Limited
Tablets release)
Glimepiride IP 2 mg
Each enteric coated tablet
Trypsin,
contains: M/s Synokem
Bromelain,
Trypsin BP 48mg Pharmaceuticals
Rutoside
67 Bromelain 90mg 1 Tablet Limited / M/s 21.80
Trihydrate and
Rutoside Trihydrate BP Neon Laboratories
Diclofenac
100mg Limited
Sodium Tablets
Diclofenac Sodium IP 50mg
Composition:
Diclofenac
Diclofenac Diethylamine IP M/s Pontika
Diethylamine,
2.32% w/w (eq. to Aerotech Limited /
Methyl
68 Diclofenac Sodium 2% w/w), 1 gram M/s Cadila 3.12
Salicylate &
Methyl Salicylate IP 10% Pharmaceuticals
Menthol Topical
w/w, Ltd.
Spray
Menthol IP 5% w/w
M/s Pure and Cure
Each film coated tablet Healthcare Pvt.
Tranexamic Acid
69 contains: 1 Tablet Ltd. / M/s Sun 18.43
Tablet
Tranexamic Acid IP 250mg Pharmaceutical
Industries Limited
Note:
(a) The manufacturer of above-mentioned formulations i.e., “new drug” under paragraph
2(1)(u) of the DPCO, 2013 shall fix the retail price as specified in column (6) of the table
hereinabove.
(b) The manufacturer may add Goods and Services Tax only if they have paid actually or it is
payable to the Government on the retail price mentioned in column (6) of the above said
table.
(c) The retail price for a pack of the aforesaid formulation shall be arrived at by the
concerned manufacturer in accordance with the retail price specified in column (6) of
the above table as per provisions contained in paragraph 11 of the DPCO, 2013. The
manufacturer shall issue a price list in Form–V from date of Notification as per
paragraph 24 of the DPCO, 2013 to NPPA through IPDMS and submit a copy to State
Drug Controller and dealers.
(d) As per para 24(4) of DPCO 2013, every retailer and dealer shall display price list and the
supplementary price list, if any, as furnished by the manufacturer, on a conspicuous part
of the premises where he carries on business in a manner so as to be easily accessible to
any person wishing to consult the same.
(e) The above mentioned retail price is applicable only to the individual manufacturer /
marketer as mentioned above i.e. who have applied for the same by submitting Form-I
for price fixation / revision as stipulated under DPCO, 2013 and subject to fulfilment of
all the applicable statutory requirements as laid down by the Govt. under relevant
statutes/ rules, including manufacturing license permission from the Competent
Authority i.e. the Central/State Licensing Authority, as may be applicable, by the
concerned manufacturer/marketing companies.
(f) In case the retail price of any of the aforesaid formulations is not complied with, as per
instant price notification and notes specified hereinabove, then the concerned
manufacturer/marketing company shall be liable to deposit the overcharged amount
along with the interest thereon under the provisions of the DPCO, 2013 read with the
Essential Commodities Act, 1955.
(g) Consequent to the fixation of retail price of such formulation as specified in column (2)
of the above table with the strength and name of Manufacturer & Marketing Companies
specified in the corresponding entries in Column (3) & (5) thereof, the price order(s)
fixing the retail price of the formulation with specified strength for that Manufacturer &
Marketing Companies as specified in corresponding entries in Column (2), (3) and (5)
thereof, if any, issued prior to this notification, stand(s) superseded.
(Mahaveer Saini)
Deputy Director (Pricing)
भारत के राजप , असाधारण के भाग-।।, ख ड 3, उपख ड (ii) म काशनाथ
भारत सरकार
रसायन और उवरक मं ालय
औषध वभाग रा य औषध मू य नधारण ा धकरण
नई द ल , 28 फरवरी 2024
आदे श
का. आ. 937(अ):- भारत सरकार के रसायन और उवरक मं ालय वारा जार का. आ. 1394 (अ) तार ख 30 मई, 2013
और का. आ. 5249(अ) तार ख 11 नव बर, 2022 के साथ प ठत औषध (क मत नयं ण) आदे श, 2013 के पैरा 5,11 और
15 वारा द शि तय का योग करते हुए, रा य औषध मू य नधारण ा धकरण (िजसको सं त प म एनपीपीए
कहा जाता है ), नीचे क सारणी के तंभ (6) म व न द ट खुदरा मू य को उ त सारणी के तंभ (3), (4) और (5) म
त थानी वि टय म व न द ट बलता, इकाई (यू नट) और व नमाता और वपणन कंप नय के नाम स हत तंभ(2) म
क त थानी वि ट म से येक क , व तु एवं सेवा कर, य द कोई है, को छोड़कर अ धकतम खुदरा मू य के प म
नयत करती है
ता लका
ता लका
(6)
(4)
सु प
(महावीर सैनी
उप िनदेशक (मू य िनधारण